• Gastrointestinal disorders like inflammatory bowel disease (IBD) are a growing challenge to health care all over the world. They often show non-distinctive clinical symptoms, leading to a complex diagnostic process before effective therapy can start
  • Detection of calprotectin and lactoferrin in stool samples are non-invasive and highly specific indicators for intestinal inflammation • Anti-Saccharomyces cerevisiae antibodies (ASCA) may help stratify patients into different types of Crohn’s disease